Profile

Cover photo
290 followers|81,450 views
AboutPostsPhotosVideos

Stream

OncLive

Shared publicly  - 
 
Frontline Nivolumab Improves Survival in Phase III Melanoma Study http://ow.ly/z1z5j
1
Add a comment...

OncLive

Shared publicly  - 
 
In 80405 ORR was 67% versus 56% with FOLFOX plus cetuximab and bevacizumab, respectively http://ow.ly/yyPzh
1
Add a comment...

OncLive

Shared publicly  - 
 
ODAC voted 11-2 against the accelerated approval of the PARP inhibitor olaparib http://ow.ly/ys9vA
1
Add a comment...

OncLive

Shared publicly  - 
 
Ramucirumab Modestly Improves Survival in Advanced NSCLC http://ow.ly/xu59z
1
Add a comment...

OncLive

Shared publicly  - 
 
Dr. Maha Hussain Discusses the ETS Gene Fusion as a Predictive Biomarker in Prostate Cancer http://ow.ly/xtAwD
1
Add a comment...

OncLive

Shared publicly  - 
 
Second Annual “Giants of Cancer Care” Announced http://ow.ly/xsnL8
1
Add a comment...
Have them in circles
290 people
LymphedemaPumpsDirect.com's profile photo
Tommy Tong's profile photo
Michael Pfaffl's profile photo
Andrew Roth's profile photo
Katie Brown's profile photo
Jeanmarie Mathieu's profile photo
Amina Kelai's profile photo
sergi gener's profile photo
HRA - Healthcare Research & Analytics's profile photo

OncLive

Shared publicly  - 
 
Two Phase III Trials Find Rolapitant Effective, Well-Tolerated for Preventing CINV http://ow.ly/yyQgt
1
Add a comment...

OncLive

Shared publicly  - 
 
Resection of the primary tumor followed by systemic treatment yielded a 4.7-month OS benefit in mCRC http://ow.ly/yyGaR
1
Add a comment...

OncLive

Shared publicly  - 
 
Dr. Nicholas Vogelzang discusses the addition of docetaxel to first-line ADT in men with prostate cancer http://ow.ly/xQJ9H
1
Add a comment...

OncLive

Shared publicly  - 
 
Treatment with ibrutinib dramatically increased PFS and OS compared with ofatumumab in relapsed CLL http://ow.ly/xtNty
1
Add a comment...

OncLive

Shared publicly  - 
 
Zoledronic Acid Can Be Administered Less Frequently in Breast Cancer http://ow.ly/xtxRM
1
Add a comment...

OncLive

Shared publicly  - 
 
Panelists discuss the utilization of second-line angiogenesis inhibitors for the treatment of patients with mRCC http://ow.ly/xmZbZ
1
Add a comment...
Story
Tagline
Bringing the Oncology Community Together
Introduction
OncLive.com is a compilation of oncology-focused research and resources that summarizes the latest information from clinical trials while highlighting news and reports from scientific conferences.  OncLive features interviews with prominent oncology researchers and peers on the latest research and guidelines.

The oncologist’s source for cancer-related content.